Skip to Content


The Division of Transplantation has earned acclaim from the international medical community for such breakthroughs as the UW-Belzer solution for organ preservation, research and clinical trials into the immunosuppressive drug mycophenolate mofetil, and improved surgical technqiues for pancreas transplantation.

Current laboratory research includes programs in organ preservation, the development of new immuosuppressants, gene therapy for diabetes as an alternative to pancreas transplantation, and induction of immunological tolerance to organ transplantation as an alternative to lifelong immunosuppression.

Active Clinical Trials

The Transplant Clinical Trials Office can be contacted at 608-263-2565.

Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation
Principal Investigator(s): Hans W. Sollinger, MD, PhD, FACS, William J Burlingham, PhD
Status: Active, not recruiting
[ NCT01053221]
More Information
Pancreas / Islet
Islet Transplantation in Type 1 Diabetic Patients Using a Steroid-free Immunosuppression Protocol and Thiazolidinedione Insulin Sensitizers
Principal Investigator(s):
Jon S Odorico, MD
Status: Active, not recruiting
[ NCT00214253]
More Information

Research Labs

Active Funding/Grants Copyright © 2015 The Board of Regents of the University of Wisconsin System